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Abstract
Venezuelan equine encephalitis (VEE) is a re-emerging, mosquito-borne viral disease with the potential to cause fatal
encephalitis in both humans and equids. Recently, detection of endemic VEE caused by enzootic strains has escalated in
Mexico, Peru, Bolivia, Colombia and Ecuador, emphasizing the importance of understanding the enzootic transmission cycle
of the etiologic agent, VEE virus (VEEV). The majority of work examining the viral determinants of vector infection has been
performed in the epizootic mosquito vector, Aedes (Ochlerotatus) taeniorhynchus. Based on the fundamental differences
between the epizootic and enzootic cycles, we hypothesized that the virus-vector interaction of the enzootic cycle is
fundamentally different from that of the epizootic model. We therefore examined the determinants for VEEV IE infection in
the enzootic vector, Culex (Melanoconion) taeniopus, and determined the number and susceptibility of midgut epithelial
cells initially infected and their distribution compared to the epizootic virus-vector interaction. Using chimeric viruses, we
demonstrated that the determinants of infection for the enzootic vector are different than those observed for the epizootic
vector. Similarly, we showed that, unlike A. taeniorhynchus infection with subtype IC VEEV, C. taeniopus does not have a
limited subpopulation of midgut cells susceptible to subtype IE VEEV. These findings support the hypothesis that the
enzootic VEEV relationship with C. taeniopus differs from the epizootic virus-vector interaction in that the determinants
appear to be found in both the nonstructural and structural regions, and initial midgut infection is not limited to a small
population of susceptible cells.
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Introduction
Venezuelan equine encephalitis virus (VEEV) has been
recognized as an etiologic agent of neurologic disease in humans
and equids for nearly 80 years. Closely related to eastern (EEEV)
and western equine encephalitis viruses (WEEV), VEEV belongs
to the family Togaviridae, genus Alphavirus. First recognized in the
1920s, Venezuelan equine encephalitis (VEE) outbreaks are
typically episodic with several years elapsing between outbreaks.
However, when outbreaks do occur, they can cause severe and
sometimes fatal disease in hundreds-of-thousands of equids and
humans. For instance, after an interval of 19 years with no
documented cases between 1973 and 1992, clusters of cases
emerged in Venezuela [1] and Chiapas, Mexico [2] prior to a
major outbreak involving ca. 100,000 people in 1995 [3]. In
general, disease manifestations of VEE range from flu-like illness
to fatal encephalitis. It is estimated that central nervous system
(CNS) involvement occurs in 4–14% of human cases, and children
are at the greatest risk to develop encephalitis and to die from
infection [4].
Of the four subtypes of VEEV, IC and IAB are considered
epizootic as they are known to cause disease in horses, to use these
hosts for amplification, and are also capable of utilizing a variety of
epizootic mosquito vectors, such as Aedes (Ochlerotatus) taeniorhynchus,
A. (Och.) sollicitans, Psorophora confinnis, Culex (Deinocerites) pseudes,
Mansonia indubitans, and M. titillans, among others [5–10]. Many of
these mosquitoes thrive near coastal brackish water, can fly long
distances from larval sites, prefer to feed on humans or other large
mammals, and can tolerate feeding in sunny areas, although they
may rest in shaded sites. In contrast, enzootic VEEV subtypes IE
and ID generally cause little or no viremia or disease in equids, but
like the epizootic strains, can cause fatal disease in humans [11–
14]. Mosquito vectors that maintain these enzootic viruses in
nature include a variety of species within the Spissipes section of the
subgenus Culex (Melanoconion), and subtype IE strains specifically
utilize C. (Mel.) taeniopus. The enzootic cycle typically occurs in
shaded, intact forests with stable pools of water that are available
for larval development. Some larvae also require the presence of a
specific aquatic plant (i.e., Pistia spp.) for respiration [15].
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Bolivia, Ecuador, Colombia and Mexico, caused by spillover of
enzootic strains in subtypes ID and IE, indicates the importance of
VEEV as a continuous public health threat in Central and South
America [16,17]. The recent documentation of widespread
endemic disease is likely associated with increased surveillance as
well as the clearing of sylvatic forest habitats to accommodate the
expansion of agricultural land types in areas of Latin America
where enzootic VEEV persists [18–20]. The resulting fragmenta-
tion of sylvatic habitats results in an increase in ecotones that can
support the life cycle of enzootic VEEV mosquito vectors [21],
which also increases the likelihood of an enzootic VEEV strain
adapting to epizootic transmission [22]. Enzootic ID strains are
known to be a source for the emergence of epizootic IC strains and
this emergence has occurred on multiple occasions [1,23]. While
IE strains had not been associated with the emergence of epizootic
strains before 1993, recent outbreaks of epizootic-like IE strains
were found to infect epizootic mosquito vectors and cause disease
in equids [2,24].
Historically, IE VEEV strains have been found in isolated
sylvatic transmission cycles between C. taeniopus mosquitoes and
rodent hosts, such as cotton rats (Sigmodon spp.), spiny rats
(Proechimys spp.) and other rodent species, including Liomys salvini
and Oligoryzomys fulvescens [25–27]. Phylogenetic studies of IE
strains show that they diverged from other subtype I VEEV
viruses, including enzootic ID strains [28], indicating that IE
strains have long been established and most likely isolated within
their enzootic habitats for at least centuries. Examination of the
low threshold for infection and specificity of IE strains for C.
taeniopus vectors suggests that IE stains have co-adapted to be
highly fit for replication in and transmission by this vector [29–31].
The stable, enzootic VEEV IE-C. taeniopus relationship is in
sharp contrast to the transient interaction that occurs between
epizootic virus strains and mosquito vectors during sporadic
outbreaks. However, the majority of experimental studies
examining VEEV-vector interactions have utilized epizootic
vectors as models. We hypothesize that IE viruses are highly
adapted to their enzootic vector through a long-term evolutionary
relationship such that the dynamics of infection of IE viruses
within their vector differ inherently from those observed in
epizootic virus-vector interactions. Reverse genetic studies of
epizootic IC VEEV indicate that infection determinants reside
within the E2 glycoprotein gene [21,24,28,32]. We hypothesized
that the transient nature of the epizootic virus limits its infection
determinants to a localized region of the genome to allow for rapid
adaptation to a competent vector, whereas the enzootic infection
determinants are not limited to a single region in the structural
portions of the genome due to the long adaptation of the genome
to infection and replication within C. taeniopus. To test this
hypothesis, we generated four chimeric VEEVs (Fig. 1), using a
strain with a known high susceptibility to C. taeniopus (i.e., subtype
IE strain 68U201) and a strain known to be poorly infectious for C.
taeniopus [i.e., subtype IAB Trinidad donkey (TrD) strain]. These
chimeras allowed us to discern the contributions of the structural
and nonstructural protein regions as well as the 39 untranslated
region (UTR) in infection and dissemination in C. taeniopus.
We also examined the initial midgut infection dynamics of the
enzootic mosquito model as compared to what has been previously
observed in the epizootic model with IC VEEV and A.
taeniorhynchus. There is only a small population of VEEV-
susceptible midgut cells in A. taeniorhynchus, and thus the midgut
infection is initiated by a very small number of infected cells and
presumably virions [32]. Evolutionary theory would suggest that a
bottleneck in the population of replicating viral genomes might
deleteriously affect viral fitness through Muller’s ratchet [33–35].
However, epizootic strains might regain fitness through recombi-
nation [32]. While this is a plausible strategy for an epizootic virus,
which only interacts transiently with its mosquito vector during an
outbreak, the enzootic virus must maintain a certain level of fitness
to persist in nature over centuries or longer and repeated
bottlenecks would likely be highly detrimental. We therefore
hypothesized that most or all midgut epithelial cells in C. taeniopus
are susceptible and, therefore, the population of enzootic VEEV
that infect the midgut epithelium does not undergo a severe
bottleneck during the infection of the midgut. To examine this
hypothesis, we utilized viral-like particles (VLP) to establish the
number, distribution, and susceptibility of midgut epithelial cells
initially infected in the IE enzootic model.
Materials and Methods
Ethical statement
This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Research Council. The protocol was
approved by the Institutional Animal Care and Use Committee of
the University of Texas Medical Branch (IACUC Protocol #
0209068, approved July 13, 2010).
Cell culture and viruses
Plaque, cytopathic effect (CPE) assays, and replication curves
were performed on Vero (African green monkey kidney), and
BHK-21 (baby hamster kidney) cells were used for electroporation
to rescue parental and recombinant viruses as well as replicon
particles from transcribed RNA. Both cell types were propagated
in Dulbecco’s modified eagle medium (DMEM) supplemented
with fetal bovine serum (FBS) and penicillin/streptomycin. For
CPE assays of mosquito samples, amphotericin B (50 mg/mL)
(Sigma-Aldrich, St. Louis, MO) was added to the DMEM. Cells
from an A. albopictus mosquito cell line, C6/36, maintained in
DMEM media supplemented with 10% FBS, penicillin/strepto-
mycin, and 1% tryptose phosphate broth (Sigma-Aldrich, St.
Louis, MO) were utilized for in vitro replicon co-infection
experiments and replication curves. Viruses used for this study
were derived from infectious cDNA clones V3000 IAB Trinidad
Donkey (TrD) (kindly provided by Nancy Davis and Robert
Author Summary
Venezuelan equine encephalitis virus (VEEV) is transmitted
to humans and horses by mosquitoes in Mexico, Central
and South America. These infections can lead to fatal
encephalitis in humans as well as horses, donkeys and
mules, and there are no licensed vaccines or treatments
available for humans. VEEV circulates in two distinct
transmission cycles (epizootic and enzootic), which are
differentiated by the ecological niche that each virus
inhabits. Epizootic strains, those that cause major out-
breaks in humans and equids, have been studied
extensively and have been used primarily to develop and
test several vaccine candidates. In this study, we demon-
strate some important differences in the roles of different
viral genes between enzootic/endemic versus epizootic
VEEV strains that affect mosquito infection as well as
differences in the way that enzootic VEEV more efficiently
infects the mosquito initially. Our findings have important
implications for designing vaccines and for understanding
the evolution of VEEV-mosquito interactions.
Enzootic VEEV in C. taeniopus
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V3000 clone, this TrD strain had been passaged once in guinea
pig brains and 14 times in embryonated eggs. The 68U201 isolate
had been passaged once in newborn mice and two times in BHK-
21 cells prior to the construction of the clone. From these clones,
four chimeric variants were developed: two with matching cis-
acting elements and two with mismatched elements (Fig. 1B and
C). Two IE replicons, 68UGFP and 68UCFP, were derived from a
full length IE 68U201 clone as previously described (Fig. 2) [32].
Replicons are replication deficient VLPs that can be utilized to
analyze the initial sites of infection without the complication of
cell-to-cell spread. These particles were generated by electropo-
rating two RNA species simultaneously. The replicon, consists of
the nonstructural open reading frame expressing a fluorescent
reporter and associated cis-acting elements; the helper contains the
structural portions of the genome. Co-electroporation of these two
RNAs generates deficient particles that are unable to package the
structural genes, but continue to express only the nonstructural
genes from the replicon packaged into the particle. Replicons and
helpers were transcribed using a T7 mMessage mMachine
(Ambion, Austin, Texas), electroporated into BHK-21 cells, and
harvested after 24 hours.
Generation of chimeric infectious clones
The first two chimeric clones were derived with mismatched cis-
acting elements to directly compare the roles of the structural and
nonstructural protein cassettes in mosquito infection and dissem-
ination. Specifically, IAB/IE had the 59 UTR and nonstructural
protein gene region derived from IAB TrD and the structural
protein gene region and 39 UTR derived from IE 68U201. The
reciprocal version, IE/IAB, had the 59 UTR and nonstructural
protein gene region of IE 68U201 and structural protein gene
region and 39 UTR derived from IAB TrD. Fusion PCR utilizing
Phusion High Fidelity Polymerase (Finnzymes, Lafayette, CO) and
designed around the Tth111I restriction enzyme site (Fig. 1) in the
26S UTR for each parental virus was used to generate a PCR
fragment joining the two different viral cDNAs. Initially, for each
reciprocal chimera, two overlapping fragments that encompassed
the fusion site of the two genomes were generated by PCR using a
forward primer from within the nsP4 region (7041 F IAB AND
6509 F IE) with a reverse fusion primer (IAB/IE R and IE/IAB R)
and reverse primer downstream of the junction site (8007 R IAB
and 8312 R) paired with a forward fusion primer for each chimera
(IAB/IE F and IE/IAB R) (Table 1). The two individual fragments
were joined by a PCR reaction on both templates utilizing the
outermost primer sets. The fusion PCR fragment was cleaved with
respective restriction enzymes (BssHII and PspOMI for IAB/IE
and Bsu36I and NheI for IE/IAB) and ligated to the two other
cDNA fragments with T4 DNA ligase (New England Biolabs,
Beverly, MA). Ligated fragments were transformed into One Shot
OmniMAX cells (Invitrogen, Carlsbad, CA), and resulting
colonies were screened and sequenced prior to cesium chloride
(CsCl) plasmid DNA purification.
The IAB/IE and IE/IAB constructs were then utilized to
generate the infectious clones with matching cis-acting elements:
Figure 1. Schematic diagram of the virus strains utilized in this study. (A) The two parental viruses included strains IE 68U201 and IAB
Trinidad Donkey (TrD). (B) IAB/IE/IAB and IE/IAB/IE were designed with matching cis-acting elements, which corresponded to the nonstructural
protein opening reading frame (ORF) of the chimera. (C) IAB/IE and IE/IAB were designed with mismatched cis-acting elements, where the 39 UTR
matched the strain used for the structural protein region of the chimera and the 59 UTR matched the strain used for the nonstructural protein region
of the chimera. Tth111I indicates the location in which the two chimeric fusion fragments were joined by PCR.
doi:10.1371/journal.pntd.0001606.g001
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IAB/IE chimeras, a fusion PCR was designed at the junction at
the end of the structural protein gene region and the start of the 39
UTR. As described above, two PCR amplicons were generated
using primers 10191 F IE, IAB/IE 39 UTR R, IAB/IE 39 UTR F,
and 12030 R for IAB/IE/IAB and 9528 F IAB, IE/IAB 39 UTR
R, IE/IAB 39 UTR F, and 12030 R for IE/IAB/IE (Table 1). The
two fragments were ligated and then cleaved with restriction
enzymes (SpeI and SacII for IAB/IE/IAB and SgrAI and EcoRI
for IE/IAB/IE) to generate a single cloning fragment. These
clones were ligated in 3 fragments, transformed, purified, and
sequenced as described above.
In vitro transcription and RNA transfection
Prior to transcription, plasmids were linearized with either NotI
(V3000 backbone) or MluI (68U201 backbone) restriction
enzymes [37,38]. RNA was generated using the mMessage T7
RNA Polymerase Kit in the presence of an analog cap (Ambion,
Austin, TX). The yield and integrity of transcripts were evaluated
by agarose gel electrophoresis directly prior to electroporation.
BHK-21 cells were electroporated using previously described
conditions [39]. Virus was harvested at 48 hours post-electropo-
ration when CPE was observed in greater than 80% of the cells.
Virus titers were determined by plaque assay on Vero cells.
Viral replication analysis
Replication kinetics of each of the two parental strains and four
chimera strains were compared on Vero and C6/36 mosquito cells
to identify any deficiencies and compare to in vivo infection and
dissemination in C. taeniopus. Cells were seeded at a concentration
of 10
6 cells/well in six well plates and allowed to attach and settle
for 4 hours. Monolayers were infected in triplicate at a multiplicity
of infection (MOI) of 5 PFU/cell and allowed to incubate for one
hour at 37uC. Following incubation, cells were washed 3 times
with phosphate-buffered saline (PBS), and overlaid with complete
DMEM. Media were collected and stored from each well and
replaced with the same volume of fresh media at predetermined
time points, followed by plaque assays to measure viral yield. To
compare the viral replication curves, a two-way ANOVA test and
post-hoc multiple comparisons test with a Bonferroni correction
was performed using JMP software, version 8.0.2 (SAS Institute
Inc., Cary, NC). P-values#0.05 were considered significant.
Figure 2. Schematic diagram of the replicons. (A) 68UGFP and (B) 68UCFP.
doi:10.1371/journal.pntd.0001606.g002
Table 1. Primers used to generate chimeras.
Name Description Sequence
IAB/IE F Tth111I Fusion Forward (A/E) AACCTGAATGGACTACGACATAGTCAAGTCCGCCGAAATG
IAB/IE R Tth111I Fusion Reverse (A/E) CATTTCGGCGGACTTGACTATGTCGTAGTCCATTCAGGTT
7041 F IAB Outer Joining Forward Primer (A/E) AGCAGAGTGTTGAGAGAACGGC
8312 R IE Outer Joining Reverse Primer (A/E) TCATTCACTCCGCCAAGCAC
IE/IAB F Tth111I Fusion Forward (E/A) AACCTGAATGGACTGCGACGTAGTCTAGTCCGCCAAGATG
IE/IAB R Tth111I Fusion Reverse (E/A) CATCTTGGCGGACTAGACTACGTCGCAGTCCATTCAGGTT
6509 F IE Outer Joining Forward primer (E/A) GCTGCCCTGTATGCAAAGACTC
8007 R IAB Outer Joining Reverse primer (E/A) CTGAATAACTTCCCTCCGACCAC
Name Description Sequence
IAB/IE 39UTR F 39UTR Forward Fusion (A/E/A) CCAACCAGAAACATAATTAGAATACAGCAGCAATTGGCAA
IAB/IE 39 UTR R 39UTR Reverse Fusion (A/E/A) TTGCCAATTGCTGCTGTATTCTAATTATGTTTCTGGTTGG
10191 F IE Outer Joining Forward (A/E/A) AAATGCTGCGGCACTCAGG
12030 R Outer Joining Reverse (Both) AGGCACCCCAGGCTTTACACT
IE/IAB 39UTR F 39UTR Forward Fusion (E/A/E) CCAACCAGAAACATAATTGATATTAGCAGCGATTGGCATG
IE/IAB 39 UTR R 39UTR Reverse Fusion (E/A/E) CATGCCAATCGCTGCTAATATCAATTATGTTTCTGGTTGG
9528 F IAB Outer Joining Forward (E/A/E) CCGGAAAAGGGTGGGAGTTTG
12030 R Outer Joining Reverse (Both) AGGCACCCCAGGCTTTACACT
doi:10.1371/journal.pntd.0001606.t001
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Two parental viruses (IAB, IE) and four chimeras (IAB/IE/
IAB, IE/IAB/IE, IE/IAB, IAB/IE) were evaluated for their
ability to infect and disseminate in C. taeniopus. The C. taeniopus
colony was established from mosquitoes collected from Chiapas,
Mexico in 2007 as described previously [40]. For all studies, 10-
week old female CD1 mice (Charles River Laboratories) were used
as viral hosts. To develop natural viremia, mice were infected with
3 log10 PFU of each virus [41] by subcutaneous (SC) inoculation,
held for 24 hours, anesthetized by intraperitoneal (IP) adminis-
tration of sodium pentobarbital (50 mg/kg), and bled via the retro-
orbital sinus to determine viremia levels. Since the replicon
particles utilized for this study do not replicate beyond the initial
cell infected, and C. taeniopus will not feed on artificial bloodmeals,
we utilized an artificial system in which we inoculated CD1 mice
intravenously (IV) allowing for an immediate nonreplicative
viremia. Mice were anesthetized by IP inoculation of sodium
pentobarbital and 200 ml of a stock replicon or a 1:1 mix of
replicons was inoculated into the tail vein. Particles were allowed
to circulate for 1–2 minutes before blood was collected from the
retro-orbital sinus to estimate the artificial viremia level achieved;
the animal was then exposed to mosquitoes for ca. one hour, after
which blood was collected again from the retro-orbital sinus to
detect any changes in the circulating replicon concentration.
Following exposure, engorged mosquitoes were sorted and
incubated for 14 days at 28uC with 75–80% humidity. A 10%
sucrose solution was provided ad libitum. Statistical analysis of rates
of infection and dissemination were broadly examined using a
contingency analysis, and specific 262 comparisons were evalu-
ated using Fisher’s exact test with JMP software (SAS Institute
Inc., Cary, NC). P-values#0.05 were considered significant.
Plaque and CPE assays
Viral titers of rescued viruses and animal sera were determined by
plaque assay on Vero cells. Following the 14-day extrinsic incubation
period (eip), legs and wings were removed from mosquitoes and
stored at 280uC. Samples were triturated, centrifuged at 95006G
for 5 minutes, and used to infect monolayers of Vero cells in CPE
assays. Triturated body samples that generated CPE were indicative
of an infected mosquito, while legs and wings were used to detect a
disseminated infection. Replicon titration was done in a similar
manner to the plaque assay; ten-fold serial-dilutions were plated on a
monolayer of Vero cells and allowed to incubate for one hour prior to
an overlay with DMEM supplemented with FBS and penicillin/
streptomycin. After 24 hours, the media were removed and the
monolayer was fixed with 4% paraformaldehyde (PFA) (Affymetrix,
Santa Clara, CA) for one hour. The number of fluorescent cells per
well was counted using an Olympus Is71 inverted fluorescent
microscope and reported as fluorescence units (FU).
Midgut dissection and processing
Mosquito samples were processed 72 hours after blood feeding to
minimize chances of damaging the midgut while distended with
blood and to allow for clear images of the midgut epithelia.
Mosquitoes were cold anesthetized and submerged for 30 seconds to
1 minute in 70% EtOH prior to being transferred to a PBS solution.
Midguts were extracted and covered with a drop of 4% PFA on a
glass slide for 30 minutes, then was rinsed twice with PBS before the
addition of ProLong Gold Antifade with DAPI (Invitrogen).
Microscopy
Mosquito midguts were imaged on an Olympus BX61
fluorescent microscope and high-resolution images were taken
on an Olympus FluoView FV1000MPE confocal microscope. In
vitro dual infection experiments were visualized on an Olympus
DSU-IX81 spinning disk confocal microscope and analyzed with
MetaMorph Software (Molecular Devices, Sunnyvale, CA).
Results
Viral replication kinetics
Figure 1 shows the genetic composition of the viruses utilized in
this study. The two parental viruses included subtype IE strain
68U201 and subtype IAB strain TrD, which share 77% nucleotide
and 89.8% amino acid identity. Four chimeric strains were derived
from these parental strains: IAB/IE/IAB and IE/IAB/IE were
designed with matching 59 and 39 cis-acting sequence elements.
IAB/IE and IE/IAB were designed with mismatched cis-acting
elements, where the 39 UTR matched the strain used for the
structural protein region of the chimera and the 59 UTR matched
the strain used for the nonstructural protein region of the chimera.
It has been shown repeatedly that conserved regions in both the 59
and 39 UTRs of alphaviruses are essential for proper synthesis of
both negative and positive strand RNA species [42–45].
Therefore, chimeras with both matching and mismatching cis-
acting elements were utilized to compare these regions of interest
and their effect on replicative efficiency.
One-step replication curves of the parental and chimeric strains
were performed on Vero cell monolayers at an MOI of five PFU/
cell to identify any replication deficiencies that could bias
experimental findings in the mosquito model. All of the chimeras
showed similar replication, with no major deficiencies when
compared to the parental strains (Fig. 3A). However, analysis of
variance indicated that the replication of the viruses was
significantly different (p,0.0001). Multiple comparison tests
showed that strain TrD exhibited higher replication levels at
multiple time points (not shown), which does not likely correlate to
the in vivo mosquito model because this strain is unable to infect
and disseminate in C. taeniopus [40,46].
One-step replication analyses were also performed on mono-
layers of C6/36 A. albopictus cells to compare to the in vivo mosquito
model (Fig. 3B). No major replication deficiencies were observed;
however, analysis of variance did indicate differences among the
viruses (p,0.0001). Unlike the Vero cell replication curves where
just the TrD strain differed from all other viruses, differences were
seen between nearly all viruses upon pairwise comparisons (not
shown). The only three pairs out of the total 15 comparisons that
did not show any statistical differences from one another were
between IE versus IE/IAB/IE, IAB/IE/IAB versus IE/IAB, and
IE/IAB/IE versus IE/IAB.
Mosquito susceptibility to chimeric viruses
Adult female C. taeniopus were exposed to a range of oral doses
for each of the parental and chimeric strains of VEEV and tested
for infection and dissemination into the hemocoel following a 14-
day eip (Table 2). Two pairs of chimeras with matched and
mismatched cis-acting elements were utilized to independently
evaluate the roles of the nonstructural and structural polyprotein
open reading frames as well as the 39 UTR in mosquito infection
and dissemination. As expected, the parental IAB TrD virus was
unable to infect C. taeniopus at blood meal titers as high as 6.2 log10
PFU/ml, which is in agreement with previous work [46,47].
Similarly, as predicted based on previous studies [30,40,46], C.
taeniopus mosquitoes were highly susceptible to infection with the
parental subtype IE 68U201 strain at oral doses as low as 4.2 log10
PFU/ml.
Enzootic VEEV in C. taeniopus
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disseminate in C. taeniopus when compared to the parental IAB and
IE strains (Table 2; Fig. 4). The effect of the exposure dose on
infection rate was evaluated by contingency analysis for each of the
chimeric viruses (IAB/IE/IAB, IE/IAB/IE, IAB/IE, and IE/IAB)
and found to be significant for each (p,0.05; p,0.001; p,0.05;
p,0.0001, respectively) (Fig. 4A). In order to compare individual
virus strains, a Fisher’s exact test was utilized to determine
differences in infection rates (Table 3). As expected, comparisons
between the parental viruses and the chimeric viruses were all
highly significant (p,0.0001), with the exception of the compar-
ison between the IE parental virus and IE/IAB chimera, for which
the IE strain had a less notable infectious advantage than the
chimera (p,0.0071). Interestingly, infection rates did not differ
significantly among three of the four chimeras: IAB/IE, IAB/IE/
IAB, and IE/IAB/IE. However, IE/IAB showed a significantly
higher infection rate when compared to each of the other three
chimeras (p,0.0001; p,0.0037; p,0.0025, respectively).
Although each chimera showed the ability to disseminate into
the hemocoel after midgut infection, the dissemination rates
among the chimeras were low overall (Figs. 4B and 4C); therefore,
no transmission experiments were performed. Previous studies of
alphaviruses as well as other arboviruses have shown that infected
mosquitoes often have virus restricted to the midgut, which is likely
explained by a commonly recognized but poorly understood
barrier to viral escape of the mosquito midgut [46,48–50]. While
dissemination rates increased as the exposure dose was increased,
the overall rates of dissemination were too low to perform reliable
statistical analysis. Fisher’s exact tests comparing the rates of
infected mosquitoes with dissemination (Fig. 4C), showed no
differences between the four chimeras.
C. taeniopus midgut infection
To observe the number of epithelial cells initially infected, the
location of the infected cells, and to determine whether there is a
subpopulation of cells within the midgut that is more susceptible
than other epithelial cells, C. taeniopus mosquitoes were exposed to
a range of doses of 68U201 replicon particles expressing
fluorescent proteins (Fig. 2). For the single replicon infections, a
clear dose-response was observed such that the lowest oral dose
Figure 3. Viral replication kinetics. Comparison of two parental viruses IAB TrD and IE 68U201 and four chimeric viruses, IAB/IE/IAB, IE/IAB/IE, IAB/
IE, and IE/IAB, at a multiplicity of infection (MOI) of 5 on Vero (A) and C6/36 (B) cells. Error bars represent the standard deviation of the means.
doi:10.1371/journal.pntd.0001606.g003
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infected only 11% of examined midguts with only 2 infected
cells/midgut, whereas the highest dose of 7.2 log10 FU/ml
infected 100% of examined midguts with a range 535–1757
infected cells/midgut (Table 4). Infected cells were not limited to
any particular region of the abdominal midgut (Fig. 5), and only a
minority of the midguts (9%) were found to have infection
focused in the posterior portion, whereas 25% showed a focused
infection in the anterior portion of the abdominal midgut. The
remaining 66% of infected midguts showed a mixed infection
with concentrated infection within the middle portion of
abdominal midgut. Infection of the midgut/foregut junction
was not observed.
C. taeniopus midgut epithelial susceptibility
To determine if there was differential susceptibility of midgut
cells, C. taeniopus mosquitoes were orally infected with a 1:1
mixture of 68UGFP and 68UCFP. A total of fifteen mosquitoes
was examined for co-infection at two different doses. The low
exposure dose achieved by artificial viremia was a mixture of 5.4
log FU/ml 68UGFP and 5.0 log FU/ml of 68UCFP, and the
high dose achieved was 6.5 log FU/ml of each replicon. At the
low dose, an average of 70 midgut epithelial cells were infected
with 68UGFP and an average of 52 cells was infected with
68UCFP. At the high dose, the average number of cells infected
with 68UGFP was 896, whereas the average number of 68UCFP
infected cells was 866. At the low dose and of the five co-exposed
mosquitoes examined, no co-infected cells were observed. At the
high dose where 15 midguts were examined, there appeared to be
2–3 cells with co-localization; however, it was determined that
these areas of co-localization were a result of either signal bleed-
through or overlap. Even so, there was still an average of less than
one observed co-infected cell per midgut in the highest dose
group.
Table 2. Virus infection and dissemination rates in C. taeniopus.
Virus BM Titer
Infection rate
[# infected/total # fed (%)]
Disseminated rate [#
disseminated/total # fed (%)]
Dissemination infection
rate [# disseminated/#
infected (%)]
IAB 3.87 0/17 (0) 0/17 (0) 0/0 (0)
5.11 0/18 (0) 0/18 (0) 0/0 (0)
6.17 0/2 (0) 0/2 (0) 0/0 (0)
IE 4.18 13/16 (81) 7/16 (44) 7/13 (53)
5.60 12/12 (100) 11/12 (92) 11/12 (92)
5.72 3/3 (100) 3/3 (100) 3/3 (100)
IAB/IE/IAB 3.85 3/8 (38) 0/8 (0) 0/3 (0)
4.81 0/16 (0) 0/16 (0) 0/0 (0)
4.90 4/8 (50) 0/8 (0) 0/4 (0)
5.77 2/4 (50) 0/4 (0) 0/2 (0)
5.81 10/19 (53) 3/19 (16) 3/10 (30)
8.50 13/23(57) 3/23(13) 3/13 (23)
8.60 3/4 (75) 2/4(50) 2/3 (66)
IE/IAB/IE 3.20 0/10 (0) 0/10 (0) 0/0 (0)
3.60 4/20 (20) 0/20 (0) 0/4 (0)
3.98 9/17 (53) 0/17(0) 0/9 (0)
5.30 1/4 (25) 0/4 (0) 0/1(0)
6.00 5/16 (31) 2/16 (13) 2/5 (40)
8.20 2/2 (100) 0/2 (0) 0/2 (0)
8.40 16/20(80) 7/20(35) 7/16 (43)
IAB/IE 4.20 8/32 (25) 0/32 (0) 0/8 (0)
4.70 7/20(35) 0/20(0) 0/7 (0)
6.00 8/18 (44) 0/18 (0) 0/8 (0)
6.23 2/22 (9) 0/22(0) 0/2 (0)
8.30 10/20(50) 7/20(35) 7/10 (70)
9.00 5/10 (50) 4/10 (40) 4/5 (80)
IE/IAB 4.60 8/27(30) 0/27(0) 0/8 (0)
5.10 11/32 (34) 0/32 (0) 0/11 (0)
5.50 22/24 (92) 7/24 (29) 7/22 (31)
5.72 3/5 (60) 2/5 (40) 2/3 (66)
8.20 30/34(88) 11/34(32) 11/30 (36)
8.30 4/4 (100) 2/4 (50) 2/4 (50)
doi:10.1371/journal.pntd.0001606.t002
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As human populations continue to expand into rural environ-
ments, the incidence of emerging and re-emerging zoonotic
pathogens will continue to climb. This has already been observed
with other arboviral viruses, such as chikungunya, dengue, yellow
fever, and Japanese encephalitis viruses [51]. Similar trends have
also been observed with enzootic strains of VEEV that have
caused endemic disease as well as outbreaks in Peru, Central
America, and Mexico [16,17]. Historically, studies of VEEV
emergence have focused on epidemic strains within subtypes IAB
and IC; however, enzootic ID and IE strains can also cause a large
burden of endemic disease, which can often be misdiagnosed as
dengue fever [52]. Recent studies have also shown that the
primary mosquito vector of enzootic IE, C. taeniopus, can be an
efficient vector of newly emerged epizootic IE strains in Mexico
[40,53]. Considering the growing risk of enzootic VEEV strains in
causing human disease, it is important to understand the
determinants and dynamics for viral infection of the primary
enzootic vector, which we hypothesize to be different from what is
known about the epizootic virus-vector interaction.
We first examined the genetic determinants of infection and
dissemination utilizing chimeric viruses to analyze the molecular
determinants for VEEV specificity to the enzootic mosquito
vector, C. taeniopus. We used two viruses with distinct phenotypes
for these chimeras, to help identify the major genome regions that
contribute to specific infection of the enzootic vector. However,
because these viruses have such a wide genetic divergence (10.2%
at the amino acid level), extrapolation of this method to clarify the
roles of each gene during enzootic mosquito infection could be
prone to bias from incompatibilities between open reading frames
within each chimera (Table 5). Therefore, to ensure that
chimerization did not result in general attenuation of virus
replication, the parental and chimeric strains were evaluated using
in vitro replication curves on Vero and C6/36 cell monolayers; no
replication deficiencies were observed. It was noted that the
replication in mosquito cells was different from what was observed
in the in vivo mosquito model in that the parental IAB virus, which
showed no deficiencies in vitro, was unable to infect the in vivo
model. Similarly, the differences observed between the IE parental
and the four chimeras in the in vivo model were not demonstrated
in the in vitro model. These results emphasize the importance of
using an in vivo mosquito model to detect differences in viral
replication, which may not be detected in a mosquito cell line.
We orally exposed C. taeniopus mosquitoes to varying doses of
two parental strains, subtype IAB TrD and subtype IE 68U201, as
Figure 4. Oral exposure dose response of each virus examined during infection and dissemination in C. taeniopus. Regression lines
were generated for each virus for the purpose of visualizing the results. Graph A represents the percentage of infection at a given dose. The goodness
of fit R
2 values were 0.995, 0.421, 0.725, 0.340, and 0.617 for IE, IAB/IE/IAB, IE/IAB/IE, IAB/IE, and IE/IAB, respectively. Graph B represents the
percentage of dissemination at a given dose, which yielded R
2 values of 0.996, 0.535, 0.465, 0.820, and 0.500 for IE, IAB/IE/IAB, IE/IAB/IE, IAB/IE, and IE/
IAB, respectively. Graph C represents the percentage of disseminated infection, which resulted in R
2 values of 0.992, 0.606, 0.2397, 0.838, and 0.305 for
IE, IAB/IE/IAB, IE/IAB/IE, IAB/IE, and IE/IAB, respectively.
doi:10.1371/journal.pntd.0001606.g004
Table 3. Two-tailed Fisher’s exact tests for infection rates of
C. taeniopus.
Virus IAB IE IAB/IE/IAB IE/IAB/IE IAB/IE IE/IAB
IAB -
IE p,0.001 -
IAB/IE/IAB p,0.001 p,0.0001 -
IE/IAB/IE p,0.001 p,0.0001 NS
a -
IAB/IE p,0.001 p,0.0001 NS
a NS
a -
IE/IAB p,0.001 p,0.0071 p,0.0025 p,0.0037 p,0.0001 -
aNS, not significant.
doi:10.1371/journal.pntd.0001606.t003
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and IE/IAB, and evaluated the role of the nonstructural and
structural protein genes and the 39 UTR as determinants of
infection and dissemination in C. taeniopus. We hypothesized that,
unlike the epizootic virus strains and their vectors, the genetic
determinants for enzootic infection include multiple genes and
they are not limited to a single region in the structural portion of
the genome. Our data supported this hypothesis, as all four
chimeras were able to infect and disseminate in C. taeniopus, albeit
at rates lower than the wild-type IE parental strain. We included
multiple replicates within each viral group to compensate for
variations within the mosquito colony. If the E2 or the structural
Table 4. Initial midgut infection of 68U201 replicons in C. taeniopus.
Replicon Group # midguts examined
Average experimental
titer (FU) # infected midguts(%) # cells infected Average # cells infected
68UGFP 9 3.00 1/9 (11) 2 n/a
a
68UGFP 13 3.76 10/13 (77) 3–21 6
68UGFP 4 6.79 4/4 (100) 50–323 130
68UGFP 8 6.81 8/8 (100) 27–393 128
68UGFP 10 7.20 10/10 (100) 535–1757 1012
an/a, not available.
doi:10.1371/journal.pntd.0001606.t004
Figure 5. Sites of 68UGFP midgut infection in C. taeniopus (106). Replicons were observed to infect the anterior, mid, and posterior portions
of the abdominal midgut at all doses of exposure.
doi:10.1371/journal.pntd.0001606.g005
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ination, those chimeras with IE-derived structural regions would
have infected mosquitoes at a higher rate than those chimeras with
IAB-derived structural regions, and this was not observed.
We anticipated that the chimeras with mismatched 39UTR
regions would show diminished infection and dissemination rates
based on previous alphavirus studies examining the effects of
mismatched cis-acting elements [54,55]; however, our IE/IAB
chimera showed a significantly higher rate of infection than that of
the other three chimeras. This suggests that the 39 UTR plays
some role in infection of the enzootic vector. A closer examination
of the effect of the 39 UTR on infection showed that the chimera
with IAB structural genes and IAB 39 UTR (IE/IAB) had the
highest infection rate, while the chimeras with a mixed structural-
39 UTR makeup (IE/IAB/IE or IAB/IE/IAB) had intermediate
infection abilities, and the chimera with IE in the structural and
the 39 UTR (IAB/IE) actually had the lowest rate of infection.
This suggests that 39 UTR acts in concert with other portions of
the genome, although it is unclear which specific regions are
important for this cooperative effect. These potential interactions
should be further explored with 39UTR-specific chimeras, such as
a IAB virus backbone with a IE derived 39UTR and a IE
backbone with a IAB-derived 39 UTR. While the role of these
regions was not mirrored by in vitro mosquito infections, our C6/
36 data were based on cells from A. albopictus, which in laboratory
experiments has been shown to be equally susceptible to epizootic
IC and enzootic ID VEEV strains [56]. Previous studies
examining chimeras between Ross River virus (RRV) and Sindbis
virus (SINV), two genetically distant alphaviruses, have shown that
mismatched 39 UTR regions can result in depressed RNA
synthesis in vitro, although the effects on replication in vivo have
not been examined [55]. However, studies of chimeras between
more closely related alphaviruses, such as o’nyong-nyong (ONNV)
and chikungunya (CHIKV) viruses, indicate that chimerization
does not have a deleterious affect on the infection of the CHIKV
mosquito vector, A. aegypti. There was also no indication that
mismatched 39 UTRs altered infection rates [57].
There were no statistical differences in the infection rates
between chimeras IAB/IE, IAB/IE/IAB, and IE/IAB/IE,
indicating that both the structural and nonstructural protein
regions of the enzootic virus play a role in vector infection, as none
of the chimeras displayed infection rates as high as the parental IE
strain. However, we observed a trend in which the two chimeras
with IE-derived nonstructural protein genes showed higher rates of
infection at higher doses. Specifically, the chimeras with IE-
derived nonstructural protein genes reached 100% infection at the
highest doses, while the chimeras with IAB-derived nonstructural
protein gene regions never reached 100% infection even at the
highest doses. The diminished infection of all chimeras implies that
there are multiple determinants of infection that reside in different
genome regions and may act synergistically. Our results show that
the determinants for infection of the enzootic vector do not reside
solely in the structural protein genes, specifically not only in the E2
glycoprotein of the genome, which supports our hypothesis that
infection determinants for VEEV in the enzootic mosquito vector
relies on both structural or nonstructural protein regions of the
genome. Interestingly, our findings suggest that in the enzootic
model, the nonstructural elements are stronger determinants of
vector infection.
We also hypothesized that the characteristics of initial midgut
infection of the enzootic mosquito vector would be inherently
different than those used by the epizootic virus in A. taeniorhynchus.
To test this hypothesis, we exposed the enzootic vector, C. taeniopus,
to replicon particles generated from a subtype IE enzootic strain.
Examination of the initial sites of infection in the midgut indicated
multiple locations in the abdominal portion with no predilection
for either the anterior or the posterior region; we detected no
infection of the cardial epithelium at the midgut/foregut junction.
Similar to what was observed in A. taeniorhynchus, a clear response
was observed between the oral dose and the number of infected
midgut cells, although the ID50 for C. taeniopus was lower and the
maximum number of infected cells was higher than the 100
susceptible A. taeniorhynchus cells previously estimated [32]. The
greater number of infected cells (.1700) in C. taeniopus following
high oral doses indicates that a larger number of its midgut
epithelial cells is susceptible to VEEV IE infection compared to A.
taeniorhynchus and VEEV IC. This observation, in conjunction with
our observation of no co-infected midgut cells in the mixed
replicon experiments, supports the hypothesis that the population
size of enzootic VEEV virions during initial infection of the midgut
is not severely restricted by a limited number of susceptible C.
taeniopus epithelial cells. The average population of cells infected by
the 68UGFP replicon at the highest dose did not differ from the
average number of cells infected by the 68UCFP replicon. This
suggests that there is no effect of co-exposure on individual particle
infection rates. Utilizing the same methods, previous studies in the
epizootic VEEV/mosquito model found an average of 26 midgut
cells co-infected with two replicons, which was greater than what
we observed in the enzootic model. This indicates that the initial
infection of the enzootic vector differs from that of the epizootic
VEEV strain. Using the Poisson distribution and given the
epizootic data (a model with a small population of susceptible
cells), we determined the probability of observing less than a single
co-infected cell out of our five C. taeniopus midgut replicates to be
5.1610
212, indicating an extremely low likelihood that there is a
subpopulation of midgut epithelial cells with enhanced suscepti-
bility.
Our studies illustrate the contrast in the virus-vector interactions
between the enzootic and epizootic VEEV cycles. Not only do
these interactions persist in different ecological cycles and infect
different species of mosquitoes, but they also behave differently
within their respective vectors. This difference may be explained
by the dissimilar selective pressures that are exerted on each
subtype during transmission. For example, epizootic viruses
produce a very high level of viremia in equids, which facilitates
VEEV transmission by epizootic vectors even if only a small
population of their midgut cells are initially infected. However, the
highly susceptible enzootic vector, which appears to have a greater
number of susceptible midget cells that can be initially infected
even after small oral doses, can transmit efficiently among
populations of rodents that develop only moderate viremia titers
[25–27].
As the growing impact of enzootic VEEV on human health is
becoming more apparent, especially after the recent emergence of
epizootic-like IE strains, understanding how these viruses interact
with vectors is critical to estimating their threat to human health
Table 5. Identity percentage between the IAB TrD and
68U201 genomes.
59 UTR (nt) nsP1(AA) nsP2(AA) nsP3(AA) nsP4(AA) 26S UTR (nt)
93% 95% 94% 69% 94% 86%
Capsid (AA) E3 (AA) E2 (AA) 6K (AA) E1 (AA) 39 UTR (nt)
86% 86% 87% 91% 93% 73%
doi:10.1371/journal.pntd.0001606.t005
Enzootic VEEV in C. taeniopus
www.plosntds.org 10 April 2012 | Volume 6 | Issue 4 | e1606and for refining public health prevention strategies as well as
developing vaccines. For instance, the design strategy of a vaccine
that is protective against epizootic and enzootic strains that are
currently causing human disease must also consider mosquito
vectors that could potentially acquire and transmit should a
vaccinee become viremic. If the epizootic vector only has a few
susceptible midgut cells and is examined for competence for a
given vaccine strain, it may appear to be incompetent. However,
the same vaccine may be able to establish an infection in the
enzootic vector. Considering that the determinants for infection
appear to differ between the two vector types, vaccine strains that
are derived from epizootic VEEV and depend on the elimination
of mosquito infection may not necessarily reflect how infectious
these vaccine candidates would be for enzootic vectors. As
enzootic habitats are encroached upon and enzootic cycles gain
close proximity to epizootic habitats, it is essential to consider the
contribution of enzootic vectors to viral emergence and the
potential introduction of vaccine strains into natural cycles.
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